These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Main Document_Covid-19_18.05.2020.docx (2.99 MB)

Screening of Chloroquine, Hydroxychloroquine and Its Derivatives for Their Binding Affinity to Multiple SARS-CoV-2 Protein Drug Targets

submitted on 25.05.2020, 03:56 and posted on 27.05.2020, 05:26 by Mallikarjuna Nimgampalle, Vasudharani Devanthan, Ambrish Saxena
Recently Chloroquine and its derivative Hydroxychloroquine have garnered enormous interest amongst the clinicians and health authorities’ world over as a potential treatment to contain COVID-19 pandemic. The present research aims at investigating the therapeutic potential of Chloroquine and its potent derivative Hydroxychloroquine against SARS-CoV-2 viral proteins. At the same time we have screened some chemically synthesized derivatives of Chloroquine and compared their binding efficacy with chemically synthesized Chloroquine derivatives through in silicoapproaches. For the purpose of the study, we have selected some essential viral proteins and enzymes implicated in SARS-CoV-2 replication and multiplication as putative drug targets.


Email Address of Submitting Author


IISER Tirupati



ORCID For Submitting Author


Declaration of Conflict of Interest


Version Notes

This is the first version


Logo branding